High res JPG file 2 (2).jpg
FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
August 12, 2020 10:07 ET | FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...
Logo  age001.jpg
FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy
August 06, 2020 07:00 ET | ORGANICELL REGENERATIVE MEDICINE, INC
MIAMI, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,...
Histogen logo 300.jpg
Histogen to Report Second Quarter 2020 Earnings on August 13, 2020
July 30, 2020 16:15 ET | Histogen Inc
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
Histogen logo 300.jpg
Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference
July 29, 2020 16:15 ET | Histogen Inc
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
July 22, 2020 17:00 ET | BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
Histogen logo 300.jpg
Histogen Inc. Announces Common Stock Purchase Agreement for up to $10 Million with Lincoln Park Capital Fund, LLC
July 20, 2020 16:10 ET | Histogen Inc
SAN DIEGO, July 20, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (“Histogen” or the “Company”) (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and...
Histogen logo 300.jpg
Histogen Announces Completion of Patient Enrollment for its HST 001 Phase 1b/2a Trial for Androgenic Alopecia in Men
July 14, 2020 05:00 ET | Histogen Inc
SAN DIEGO, July 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Announces Submission of Applications for Q-Codes from the Centers for Medicare and Medicaid Services (CMS)
July 02, 2020 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, FL, July 02, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a leading life sciences company specializing in the development and commercialization of perinatal...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Announces Tissue Bank Certification in California and Maryland
June 26, 2020 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, FL, June 26, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based...
Surrozen Logo FINAL Large-1.png
UPDATE -- Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials
June 19, 2020 10:00 ET | Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...